Keith Gagnon's profile

Keith Gagnon

Principal Investigator

Wake Forest Baptist Medical Center

I'm working on

8 months ago

Genome Editing and RNA Therapeutics, Nucleic Acid Chemistry, Neurogenetics

About

Keith Gagnon advances CRISPR and RNA medicines, with issued patents on repeat‑targeted RNAs and anti‑CRISPR inhibitors. Supported by multi‑million‑dollar translational funding, he is building neurodegenerative disease programs and a spinout, Iris Medicine.

Partnering listings

Learn more

Wake Forest Baptist Medical Center

Allele-selective epigenetic silencing for repeat expansion disorders

DiscO editing platform offers allele-selective epigenetic silencing of disease-associated repeat expansion genes. Utilizing engineered IscB fused with silencing domains, it targets CAG and CTG repeats in Huntington’s dis...

TechnologyConceptualUniversity

Keith Gagnon

Principal Investigator

Wake Forest Baptist Medical Center

Work experience

Wake Forest Baptist Medical Center

Principal Investigator

Top industry applications

Neurology & neurological diseasePharmaceuticals and drug delivery

Open to opportunities in

Biochemical EngineeringBiochemistryTranslational Science

Last updated Feb 2026